Quantification of dispersion of Gd-DTPA from the initial area of enhancement into the peritumoral zone of edema in brain tumors

Journal of Neuro-Oncology

Volumn 94, Issue 3, 2009, Pages 399-408

  Pronin, Igor N ^a   McManus, Kathleen A ^b   Holodny, Andrei I ^b   Peck, Kyung K ^b   Kornienko, Valeri N ^a  

^a BURDENKO NEUROSURGICAL INSTITUTE   (Russian Federation)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Brain tumors; Gadolinium; Glioma; Neurosurgery

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN EDEMA; BRAIN TUMOR; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DRUG DISTRIBUTION; FEMALE; GLIOBLASTOMA; HUMAN; MALE; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS;

AGED; BRAIN EDEMA; BRAIN MAPPING; BRAIN NEOPLASMS; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; TIME FACTORS;

EID: 69249248205     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-9872-x     Document Type: Article

References (40)

1. Felix R, Schörner W, Laniado M et al (1985) Brain tumors: MR imaging with gadolinium-DTPA. Radiology 156:681-688
2. Carr DH, Brown J, Bydder GM et al (1984) Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumours. Lancet 1:484-486. doi: 10.1016/S0140-6736(84)92852-6
3. Graif M, Bydder GM, Steiner RE et al (1985) Contrast-enhanced MR imaging of malignant brain tumors. AJNR Am J Neuroradiol 6:855-862
4. Claussen C, Laniado M, Kazner E et al (1985) Application of contrast agents in CT and MRI (NMR): Their potential in imaging of brain tumors. Neuroradiology 27:164-171. doi: 10.1007/BF00343790
5. Brant-Zawadzki M, Berry I, Osaki L et al (1986) Gd-DTPA in clinical MR of the brain: 1. Intraaxial lesions. AJR Am J Roentgenol 147:1223-1230
6. Carollo BR, Runge VM, Price AC et al (1990) The prospective evaluation of gd-DTPA in 225 consecutive cranial cases: Adverse reactions and diagnostic value. Magn Reson Imaging 8:381-393. doi: 10.1016/ 0730-725X(90)90046-5
7. Knauth M, Wirtz CR, Tronnier VM et al (1999) Intraoperative MR imaging increases the extent of tumor resection in patients with high-grade gliomas. AJNR Am J Neuroradiol 20:1642-1646
8. Schellinger PD, Meinck HM, Thron A (1999) Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J Neurooncol 44:275-281. doi: 10.1023/A:1006308808769
9. Shih JL, Brugger RM (1992) Gadolinium as a neutron capture therapy agent. Med Phys 19:733-744. doi: 10.1118/1.596817
10. Ito U, Reulen HJ, Tomita H et al (1990) A computed tomography study on formation, propagation, and resolution of edema fluid in metastatic brain tumors. Adv Neurol 52:459-468
11. Terada T, Nakamura Y, Tsuura M et al (1992) MRI changes in embolized meningiomas. Neuroradiology 34:162-167. doi: 10.1007/BF00588165
12. Groothuis DR, Lapin GD, Vriesendorp FJ et al (1991) A method to quantitatively measure transcapillary transport of iodinated compounds in canine brain tumors with computed tomography. J Cereb Blood Flow Metab 11:939-948
13. Yeung W, Lee TY, Del Maestro RF, Kozak R, Brown T (1992) In vivo CT measurement of blood-brain transfer constant of iopamidol in human brain tumors. J Neurooncol 14:177-187
14. Ito U, Tomita H, Tone O, Masaoka H, Tominaga B (1994) Peritumoral edema in meningioma: A contrast enhanced CT study. Acta Neurochir Suppl (Wien) 60:361-364
15. Aaslid R, Gröger U, Patlak CS et al (1990) Fluid flow rates in human peritumoural oedema. Acta Neurochir Suppl (Wien) 51:152-154
16. Nagashima T, Tamaki N, Takada M et al (1994) Formation and resolution of brain edema associated with brain tumors. A comprehensive theoretical model and clinical analysis. Acta Neurochir Suppl (Wien) 60:165-167
17. Ohata K, Marmarou A (1992) Clearance of brain edema and macromolecules through the cortical extracellular space. J Neurosurg 77:387-396
18. Bitzer M, Nägele T, Geist-Barth B et al (2000) Role of hydrodynamic processes in the pathogenesis of peritumoral brain edema in meningiomas. J Neurosurg 93:594-604
19. Wrba E, Nehring V, Chang RC, Baethmann A, Reulen HJ, Uhl E (1997) Quantitative analysis of brain edema resolution into the cerebral ventricles and subarachnoid space. Acta Neurochir Suppl (Wien) 70:288-290
20. Runge VM (1988) Gd-DTPA: An i.v. contrast agent for clinical MRI. Int J Radiat Appl Instrum B 15:37-44. doi: 10.1016/0883-2897(88)90158-4
21. Yuh WT, Tali ET, Nguyen HD et al (1995) The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. AJNR Am J Neuroradiol 16:373-380
22. Healy ME, Hesselink JR, Press GA et al (1987) Increased detection of intracranial metastases with intravenous gd-DTPA. Radiology 165:619-624
23. Russell EJ, Geremia GK, Johnson CE et al (1987) Multiple cerebral metastases: Detectability with gd-DTPA-enhanced MR imaging. Radiology 165:609-617
24. Haustein J, Laniado M, Niendorf HP et al (1992) Administration of gadopentetate dimeglumine in MR imaging of intracranial tumors: Dosage and field strength. AJNR Am J Neuroradiol 13:1199-1206
25. Sze G, Milano E, Johnson C, Heier L (1990) Detection of brain metastases: Comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR Am J Neuroradiol 11:785-791
26. Pronin IN, Holodny AI, Petraikin AV (1997) MRI of high-grade glial tumors: Correlation between the degree of contrast enhancement and the volume of surrounding edema. Neuroradiology 39:348-350. doi: 10.1007/ s002340050421
27. Tofts PS (1997) Modeling tracer kinetics in dynamic gd-DTPA MR imaging. J Magn Reson Imaging 7:91-101. doi: 10.1002/jmri.1880070113
28. Choyke PL, Dwyer AJ, Knopp MV (2003) Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 17:509-520. doi: 10.1002/jmri.10304
29. Tofts PS, Kermode AG (1991) Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 17:357-367. doi: 10.1002/mrm.1910170208
30. Ott RJ, Brada M, Flower MA et al (1991) Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. Eur J Cancer 27:1356-1361
31. Reulen HJ, Tsuyumu M, Tack A et al (1978) Clearance of edema fluid into cerebrospinal fluid. A mechanism for resolution of vasogenic brain edema. J Neurosurg 48:754-764
32. Shulman K, Marmarou A, Weitz SN (1975) Gradients of brain interstitial fluid pressure in experimental brain infusion and compression. In: Lundberg N, Ponten U, Brock M (eds) Intracranial pressure II. Springer, Berlin, pp 221-223
33. Tsuyumu M, Reulen HJ, Prioleau G (1981) Dynamics of formation and resolution of vasogenic brain oedema. I. Measurement of oedema clearance into ventricular CSF. Acta Neurochir (Wien) 57:1-13. doi: 10.1007/ BF01665107
34. Nagashima T, Tada Y, Hamano S et al (1990) The finite element analysis of brain oedema associated with intracranial meningiomas. Acta Neurochir Suppl (Wien) 51:155-157
35. Hofmann B, Fischer CO, Lawaczeck R et al (1999) Gadolinium neutron capture therapy (GdNCT) of melanoma cells and solid tumors with the magnetic resonance imaging contrast agent gadobutrol. Investig Radiol 34:126-133. doi: 10.1097/00004424-199902000-00005
36. Miyatake S, Tamura Y, Kawabata S et al (2007) Boron neutron capture therapy for malignant tumors related to meningiomas. Neurosurgery 61:82-90. doi: 10.1227/01.neu.0000279727.90650.24
37. De Stasio G, Rajesh D, Casalbore P et al (2005) Are gadolinium contrast agents suitable for gadolinium neutron capture therapy? Neurol Res 27:387-398. doi: 10.1179/016164105X17206
38. De Stasio G, Casalbore P, Pallini R et al (2001) Gadolinium in human glioblastoma cells for gadolinium neutron capture therapy. Cancer Res 61:4272-4277
39. Haustein J, Laniado M, Niendorf HP et al (1993) Triple-dose versus standard-dose gadopentetate dimeglumine: A randomized study in 199 patients. Radiology 186:855-860
40. Erickson BJ, Campeau NG, Schreiner SA et al (2002) Triple-dose contrast/ magnetization transfer suppressed imaging of 'non-enhancing' brain gliomas. J Neurooncol 60:25-29. doi: 10.1023/A:1020274110502